Nephron Pharmaceuticals Corp. recalls Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator Refills (Racepinephrine USP 11.25 mg), 30 individual foi…
- Recall date
- August 21, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0389-2016
- FDA classification
- Class II
- Brand / firm
- Nephron Pharmaceuticals Corp.
- Sold / distributed
- Nationwide
Why it was recalled
Discoloration
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator Refills (Racepinephrine USP 11.25 mg), 30 individual foil wrapped vials per carton, Manufactured By: nephron pharmaceuticals corporation, Orlando, FL --- NDC 0487-2784-01
Get recall alerts
Free email alert whenever Nephron Pharmaceuticals Corp. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Nephron Pharmaceuticals Corp.